Ssieoseu Technology Signs MOU with PureHealth, the Largest Healthcare Group in the Middle East
Wearable AI diagnostic monitoring company Ssieoseu Technology announced on February 11 that it has signed a memorandum of understanding (MOU) with PureHealth Group, the largest healthcare group in the United Arab Emirates (UAE), to cooperate on an AI-based patient monitoring business.
The agreement was signed on February 10 (local time) at the One Health booth during the global medical exhibition "WHX Dubai 2026 (World Health Expo Dubai)" held in Dubai. Adnan Anjum, Chief Digital Officer of PureHealth and CEO of its digital healthcare subsidiary One Health, attended as a signatory, and Qasim Ahmad, Head of Innovation at PureHealth, was also present. In addition, officials from the Korea Trade-Investment Promotion Agency (KOTRA) and the Korea International Trade Association attended, adding significance in terms of expanding digital healthcare cooperation between Korea and the UAE.
Lee Youngshin, CEO of Seers Technology (left), and Anjum Adnan, Chief Digital Officer of PureHealth and CEO of its digital healthcare subsidiary OneHealth, are taking a commemorative photo after the MOU signing ceremony at the OneHealth booth at 'WHX Dubai 2026'. Seers Technology
View original imageSsieoseu has been building a local cooperation base with One Health, the digital healthcare subsidiary within the PureHealth Group. With this MOU, the cooperation partner has expanded to the group level, and Ssieoseu expects its role and status as a business operator in the UAE digital healthcare market to be further strengthened.
The two companies plan to sequentially implement pilot programs for the entire product lineup, including mobiCARE™, a wearable electrocardiogram-based cardiac monitoring solution, thynC™, an inpatient monitoring platform, and remote patient monitoring (RPM, Remote Patient Monitoring) for home-care patients. In this phase, they will verify user experience, medical staff acceptance, and operational efficiency based on data collected in real clinical settings, and identify potential bottlenecks that may arise during operations. They also plan to confirm return on investment (ROI) and improvements in hospital operational efficiency, and then gradually expand the scope of deployment based on the validated results. In particular, they aim to establish a continuous patient management system that connects hospitalization, outpatient care, health checkups, and home care, and to strengthen a data-driven integrated patient management environment.
Ssieoseu is currently preparing clinical and operational implementation focused on major medical institutions in the UAE, and is conducting operational validation in real clinical settings starting with Sheikh Shakhbout Medical City (SSMC) under PureHealth. Based on the pilot results, the company expects that supply and business expansion will be carried out step by step.
The Middle East (MENA) region, including the UAE, is a large market with approximately 800,000 hospital beds, and demand for digital healthcare is rapidly increasing as investment in medical infrastructure expands and chronic diseases become more prevalent. The company explained that the Middle East market is highly attractive, noting that the number of patients with hypertension and cardiovascular diseases is about three times higher than in Korea, and medical fees are up to four times higher than in Korea. It also assessed that the per-bed patient monitoring unit price is more than two to three times higher than in Korea, and therefore a business structure that extends from inpatient monitoring to remote patient monitoring (RPM) for home-care patients is expected to generate profitability leverage effects.
PureHealth operates its digital health business through its digital healthcare subsidiary One Health and is the largest integrated healthcare group in the Middle East, operating more than 100 hospitals and more than 300 clinics and employing more than 56,000 healthcare professionals. It generates annual revenue of approximately 25.8 billion dirhams (AED), or about 8.9 trillion won, and has built a nationwide medical infrastructure spanning medical care, insurance, diagnostics, and distribution, including SEHA, the Abu Dhabi public hospital network; DAMAN, the largest health insurer in the UAE; and PureLab, the largest testing network. Recently, it has also been accelerating its expansion into a global healthcare platform, including the acquisition of Circle Health Group, the largest private healthcare provider in the United Kingdom, in a deal worth about 1.2 billion dollars.
Hot Picks Today
"I Want to Be as Beautiful as Korean Women": Fo...
- Chilling Timing "Did They Know Again?"... $640 Million Suspicious Bet Just 15 Mi...
- Trump: "Iran in a Crazy Situation... Orders to Fire on Mine-Laying Vessels in th...
- "If You Have This at Home, Remove It Immediately"... 'This Item' Is as Harmful a...
- "I Spent Money in a Truly Meaningful Way"... How an SK hynix Employee Donated 10...
Lee Youngshin, CEO of Ssieoseu, said, "This MOU goes beyond simple cooperation and is highly meaningful in that Korean wearable AI medical technology has been recognized for its competitiveness even in the UAE, a leading global medical market," adding, "As the introduction of thynC is currently being pursued mainly at SSMC under PureHealth, we will gradually push forward commercialization so that the pilot results lead to actual supply and revenue."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.